Cargando…
P124 Differences in OSA pathophysiological traits between mandibular advancement therapy responders versus non-responses and the influence of obesity
Mandibular advancement therapy (MAS) is a recognised second-line therapy for obstructive sleep apnoea (OSA). However, MAS treatment outcomes vary and are difficult to predict. Recent studies have investigated the role of OSA endotypes to predict MAS therapy outcomes. However, whether OSA endotype pr...
Autores principales: | Tong, B, Chiang, A, Naik, G, Osman, A, Bull, C, Donegan, M, Pinczel, A, Rawson, G, Pitcher, G, Brown, E, Kwan, B, Mukherjee, S, Adams, R, Eckert, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108956/ http://dx.doi.org/10.1093/sleepadvances/zpac029.192 |
Ejemplares similares
-
P149 The role of OSA pathophysiological traits on mandibular advancement treatment response and efficacy of a novel mandibular advancement device
por: Tong, B, et al.
Publicado: (2021) -
O026 Effect of oral appliance therapy on OSA endotypes
por: Osman, A, et al.
Publicado: (2022) -
P004 Addition of an oral expiratory positive pressure valve (EPAP) to an oral appliance therapy device can resolve obstructive sleep aponea (OSA)
por: Aishah, A, et al.
Publicado: (2022) -
P002 Targeted non-CPAP combination therapy resolves obstructive sleep apnoea
por: Aishah, A, et al.
Publicado: (2021) -
O023 Impact of weight loss of OSA pathophysiology
por: Wong, A, et al.
Publicado: (2021)